Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Poly(ADP-ribose) polymerase inhibitor olaparib hampers placental growth factor-driven activation of myelomonocytic cells.

Lacal PM, Atzori MG, Ruffini F, Tentori L, Graziani G.

Oncol Rep. 2018 May;39(5):2261-2269. doi: 10.3892/or.2018.6291. Epub 2018 Mar 5.

PMID:
29512738
2.

The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo.

Atzori MG, Tentori L, Ruffini F, Ceci C, Bonanno E, Scimeca M, Lacal PM, Graziani G.

J Pharmacol Exp Ther. 2018 Jan;364(1):77-86. doi: 10.1124/jpet.117.244434. Epub 2017 Oct 12.

PMID:
29025978
3.

Platelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.

Ruffini F, Levati L, Graziani G, Caporali S, Atzori MG, D'Atri S, Lacal PM.

Oncotarget. 2017 Jun 27;8(40):66833-66848. doi: 10.18632/oncotarget.18706. eCollection 2017 Sep 15.

4.

The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.

Atzori MG, Tentori L, Ruffini F, Ceci C, Lisi L, Bonanno E, Scimeca M, Eskilsson E, Daubon T, Miletic H, Ricci Vitiani L, Pallini R, Navarra P, Bjerkvig R, D'Atri S, Lacal PM, Graziani G.

J Exp Clin Cancer Res. 2017 Aug 10;36(1):106. doi: 10.1186/s13046-017-0577-2.

5.

Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth.

Ceci C, Tentori L, Atzori MG, Lacal PM, Bonanno E, Scimeca M, Cicconi R, Mattei M, de Martino MG, Vespasiani G, Miano R, Graziani G.

Nutrients. 2016 Nov 22;8(11). pii: E744.

6.

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.

Graziani G, Ruffini F, Tentori L, Scimeca M, Dorio AS, Atzori MG, Failla CM, Morea V, Bonanno E, D'Atri S, Lacal PM.

Oncotarget. 2016 Nov 8;7(45):72868-72885. doi: 10.18632/oncotarget.12108.

7.

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.

Graziani G, Artuso S, De Luca A, Muzi A, Rotili D, Scimeca M, Atzori MG, Ceci C, Mai A, Leonetti C, Levati L, Bonanno E, Tentori L, Caccuri AM.

Biochem Pharmacol. 2015 May 1;95(1):16-27. doi: 10.1016/j.bcp.2015.03.004. Epub 2015 Mar 17.

PMID:
25795251
8.

NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.

Caporali S, Levati L, Graziani G, Muzi A, Atzori MG, Bonmassar E, Palmieri G, Ascierto PA, D'Atri S.

J Transl Med. 2012 Dec 21;10:252. doi: 10.1186/1479-5876-10-252.

9.

Substance P in the human brainstem. Preliminary results of its immunohistochemical localization.

Del Fiacco M, Dessi ML, Atzori MG, Levanti MC.

Brain Res. 1983 Mar 28;264(1):142-7.

PMID:
6189551

Supplemental Content

Loading ...
Support Center